FRI Drug Discovery Research Stream
From Lab to Life: Discover New Pathways to Combat Diseases with Cutting-Edge Therapies
Drug discovery focuses on how organic molecules function and, in turn, then can be used to address medical problems. The research carried out by first-year students in the Drug Discovery research stream at Binghamton University contributes to better understanding of how to improve targeted delivery of biomedicine in the human body. In particular, the stream research focuses on understanding the role and requirement of biomolecules in neurological disorders and cancer. Researchers within this steam will identify molecular targets for therapeutic treatment.

Drug Discovery research intersects the traditional disciplines of Pharmacology, Chemistry, Genetics, Biology, Medicinal Chemistry, Cellular Biology, Neurochemistry, and Molecular Biology. The research questions our FRI students explore are to investigate biomolecules in neurodegenerative diseases and cancer to better understand how they function and, in turn, provide insight in targeting and designing novel medicinal therapies.
All of the research projects in this field will advance medicinal practices. Each discipline, neurochemistry, genetics, molecular and cellular biology, biophysics, medicinal chemistry, and pharmacology, is intertwined to allow for an increased understanding of cellular complexities and will aid in developing therapeutic avenues to support public health.
Research Themes
![]() Slowing Cancer Cell Growth
|
![]() Reducing Side Effects
|
|
![]() Novel Drug Combinations
|
![]() Natural Product Therapies
|
Research Educator
Patricia Wolfe
Drug Discovery, Research Assistant Professor
Research Interests
- Cell Biology
- Pharmacology
- Nutritional Biology
Research Techniques

Research Projects
-
Cohort 11 (2024-2025)
- Bridging immunology and oncology: Utilizing JAK inhibitors and chemotherapy drugs to treat pancreatic cancer
- Effect of thiamine-like drugs on transketolase activity in FL83B cells
- Evaluating hepatoprotectivity of glycyrrhizin and silibinin for pyrazinamide-induced liver injury
- G-quadruplexes as drug targets for pancreatic cancer
- Toxicity of biofilm releasing agents in FL83B cells

-
Cohort 10 (2023-2024)
- Effect of TLR-7 inhibition on an agonist-induced HEK-Blue TLR7 cell line
- Stabilization of MYC G-quadruplex by small molecule ligands
- Synergistic effects of MMP-9 and tubulin inhibition in A549 lung carcinoma cells
- Synergistic treatment with puromycin and vorinostat of MYC-driven lung cancer
- The synergistic effect of natural compounds on combating non-alcoholic fatty liver disease

Research Stream Collaborators
Tony Davis
Assistant Professor, Pharmaceutical Sciences
Research Interests
- Natural products biosynthesis
- Infectious diseases
- Targeted protein degradation
- Drug discovery and development
- Chemical biology
- Synthetic and medicinal chemistry
Tracy Brooks
Chair and Associate Professor, Pharmaceutical Sciences
Research Interests
- Oncology
- Anti-cancer therapeutics
- Drug target development
Katie Edwards
Research Associate Professor, Pharmaceutical Sciences
Research Interests
- Bioanalytical assay development (enzyme-focused)
- Thiamine metabolism and functional biomarkers
- Transketolase and related metabolic pathways
- Oxidative stress and redox systems
- Bioactivity of natural products
Research Interests
- Organic chemistry
- Bio-organic chemistry
- Medicinal chemistry
- Biological chemistry
- Pharmaceutical chemistry
- Chemical biology
- Drug discovery
Nathan Tumey
Vice Chair and Associate Professor, Pharmaceutical Sciences
Research Interests
- Medicinal chemistry
- Targeted drug delivery
- Antibody-drug conjugates
- Autoimmune disease / inflammation / oncology



